MARIA POWERS: Open Payments
NPI 1215451893 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 60 payments from 19 companies in 2025. Trend: 2023 $1,164 · 2024 $1,167 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $429 |
| Janssen Biotech, Inc. | 7 | $166 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| Madrigal Pharmaceuticals | 5 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $132 |
| Aimmune Therapeutics, Inc. | 5 | $100 |
| Braintree Laboratories, Inc. | 3 | $62 |
| Mallinckrodt Hospital Products Inc. | 2 | $55 |
| GENZYME CORPORATION | 2 | $47 |
| Gilead Sciences, Inc. | 2 | $39 |
Products named: RINVOQ, TREMFYA, SKYRIZI, AMVUTTRA, REZDIFFRA, VOWST, ENTYVIO, CREON.
Industry payments across FL — which companies pay providers there.
